IRIDEX Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
IRIDEX's earnings have been declining at an average annual rate of -2.3%, while the Medical Equipment industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 7% per year.
Anahtar bilgiler
-2.3%
Kazanç büyüme oranı
3.1%
EPS büyüme oranı
Medical Equipment Sektör Büyümesi | 8.9% |
Gelir büyüme oranı | 7.0% |
Özkaynak getirisi | -255.7% |
Net Marj | -21.8% |
Son Kazanç Güncellemesi | 29 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Revenues Working Against IRIDEX Corporation's (NASDAQ:IRIX) Share Price Following 26% Dive
Jun 11Is IRIDEX (NASDAQ:IRIX) In A Good Position To Invest In Growth?
May 14Iridex's Strategic Review Process Should Bear Fruit 'Soon'
Mar 28Little Excitement Around IRIDEX Corporation's (NASDAQ:IRIX) Revenues
Feb 14Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?
Oct 04Lacklustre Performance Is Driving IRIDEX Corporation's (NASDAQ:IRIX) 32% Price Drop
Aug 12Will IRIDEX (NASDAQ:IRIX) Spend Its Cash Wisely?
Apr 14We're Hopeful That IRIDEX (NASDAQ:IRIX) Will Use Its Cash Wisely
Oct 12Is IRIDEX (NASDAQ:IRIX) Using Too Much Debt?
Feb 25Iridex To Benefit From New Revolutionary Glaucoma Treatment
Jan 11Analysts Expect Breakeven For IRIDEX Corporation (NASDAQ:IRIX) Before Long
Jan 03IRIDEX says laser therapy now accepted in the European Glaucoma Society guidelines
Dec 23Gelir ve Gider Dağılımı
IRIDEX nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
29 Jun 24 | 50 | -11 | 25 | 6 |
30 Mar 24 | 50 | -11 | 25 | 7 |
30 Dec 23 | 52 | -10 | 25 | 7 |
30 Sep 23 | 55 | -8 | 25 | 7 |
01 Jul 23 | 56 | -8 | 26 | 7 |
01 Apr 23 | 57 | -7 | 26 | 7 |
31 Dec 22 | 57 | -8 | 26 | 7 |
01 Oct 22 | 57 | -9 | 25 | 8 |
02 Jul 22 | 56 | -9 | 25 | 8 |
02 Apr 22 | 55 | -6 | 24 | 8 |
01 Jan 22 | 54 | -5 | 23 | 7 |
02 Oct 21 | 51 | -3 | 22 | 6 |
03 Jul 21 | 46 | -3 | 21 | 5 |
03 Apr 21 | 39 | -7 | 20 | 4 |
02 Jan 21 | 36 | -6 | 19 | 3 |
26 Sep 20 | 36 | -8 | 20 | 3 |
27 Jun 20 | 38 | -8 | 20 | 3 |
28 Mar 20 | 42 | -7 | 22 | 3 |
28 Dec 19 | 43 | -9 | 23 | 4 |
28 Sep 19 | 43 | -10 | 24 | 4 |
29 Jun 19 | 44 | -11 | 26 | 4 |
30 Mar 19 | 44 | -12 | 26 | 4 |
29 Dec 18 | 43 | -13 | 26 | 4 |
29 Sep 18 | 41 | -15 | 26 | 4 |
30 Jun 18 | 41 | -15 | 26 | 5 |
31 Mar 18 | 41 | -15 | 25 | 5 |
30 Dec 17 | 42 | -13 | 23 | 5 |
30 Sep 17 | 44 | -19 | 22 | 5 |
01 Jul 17 | 43 | -16 | 20 | 5 |
01 Apr 17 | 45 | -14 | 19 | 5 |
31 Dec 16 | 46 | -12 | 18 | 5 |
01 Oct 16 | 46 | 0 | 17 | 5 |
02 Jul 16 | 46 | 1 | 16 | 5 |
02 Apr 16 | 43 | 0 | 15 | 5 |
02 Jan 16 | 42 | 0 | 14 | 5 |
03 Oct 15 | 41 | 9 | 15 | 5 |
04 Jul 15 | 42 | 9 | 15 | 5 |
04 Apr 15 | 43 | 10 | 15 | 5 |
03 Jan 15 | 43 | 10 | 14 | 5 |
27 Sep 14 | 42 | 2 | 14 | 4 |
28 Jun 14 | 41 | 2 | 14 | 4 |
29 Mar 14 | 40 | 2 | 13 | 4 |
28 Dec 13 | 38 | 2 | 13 | 4 |
Kaliteli Kazançlar: IRIX is currently unprofitable.
Büyüyen Kar Marjı: IRIX is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: IRIX is unprofitable, and losses have increased over the past 5 years at a rate of 2.3% per year.
Büyüme Hızlandırma: Unable to compare IRIX's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: IRIX is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (11.7%).
Özkaynak Getirisi
Yüksek ROE: IRIX has a negative Return on Equity (-255.7%), as it is currently unprofitable.